Despite good revenue growth, the market expected more, as se...
Despite good revenue growth, the market expected more, as seen in the share price drop. This could hint at delayed revenue growth. The recent sell-off might be an investment chance considering the signs of a continued growth trend.
Further Weakness as Avid Bioservices (NASDAQ:CDMO) Drops 19% This Week, Taking One-year Losses to 66%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment